Table of Indications and Regimens from the National Cancer Control Programme, Ireland

Description: A table containing all indications published by the National Cancer Control Programme (NCCP), Ireland. Each entry has an indication code, description, and disease; regimen code, name, and URL; and information regarding whether the indication contains molecular diagnostic criteria. Entries were last updated from the NCCP website on 2025-May-27. Headings: IndicationCode: NCCP indication code (ex: 00537a). IndicationDesc: Description of the indication taken from its relevant regimen (ex: "Monotherapy for the treatment of adults with relapsed or refractory CD22-positive B cell precursor acute lymphoblastic leukaemia (ALL). Adult patients with Philadelphia chromosome positive (Ph+) relapsed or refractory B cell precursor ALL should have failed treatment with at least 1 tyrosine kinase inhibitor (TKI).") CancerType: Manual annotation of disease category for the indication (ex: Leukaemia). HasGeneticCriteria: Manual TRUE/FALSE annotation indicating the presence or absence of genetic criteria for the indication, as described in the indication description or regimen document. GeneticCriteria: If HasGeneticCriteria is TRUE, the relevant criteria listed (ex: BCR-ABL1 positive). HasBiomarkerCriteria: Manual TRUE/FALSE annotation indicating the presence or absence of cellular biomarker criteria for the indication, as described in the indication description or regimen document. BiomarkerCriteria: If HasBiomarkerCriteria is TRUE, the relevant criteria listed (ex: CD22+). HasMolecularCriteria: For convenience, column stating TRUE if HasBiomarkerCriteria is True or HasGeneticCriteria is True. RegimenCode: NCCP code for the regimen associated with the indication (ex: 537). RegimenName: NCCP regimen name (ex: Inotuzumab ozogamicin Monotherapy) NCCPRegimenCategories: NCCP disease categories associated with the regimen (ex: Leukaemia/BMT). RegimenURL: URL to the NCCP regimen document. Notes: Miscellaneous notes containing notes from NCCP regimen documents or further explanations.本数据集收录爱尔兰国家癌症控制计划（National Cancer Control Programme, NCCP）发布的全部适应证条目。每条记录包含适应证编码、描述与疾病类型；治疗方案编码、名称与访问链接；以及该适应证是否包含分子诊断标准的相关信息。本数据集最新更新于2025年5月27日，数据源自NCCP官方网站。 各字段说明如下： IndicationCode: NCCP适应证编码（示例：00537a）。 IndicationDesc: 从对应治疗方案中提取的适应证描述（示例："成人复发性或难治性CD22阳性B细胞前体急性淋巴细胞白血病（Acute Lymphoblastic Leukaemia, ALL）单药治疗。费城染色体阳性（Ph+）复发性或难治性B细胞前体急性淋巴细胞白血病成人患者，需经至少1种酪氨酸激酶抑制剂（Tyrosine Kinase Inhibitor, TKI）治疗失败后方可适用。"） CancerType: 为该适应证手动标注的疾病分类（示例：白血病）。 HasGeneticCriteria: 手动标注的TRUE/FALSE值，用于指示该适应证是否存在遗传相关诊断标准，判定依据为适应证描述或治疗方案文档。 GeneticCriteria: 若HasGeneticCriteria取值为TRUE，则列出对应的诊断标准（示例：BCR-ABL1阳性）。 HasBiomarkerCriteria: 手动标注的TRUE/FALSE值，用于指示该适应证是否存在细胞生物标志物相关诊断标准，判定依据为适应证描述或治疗方案文档。 BiomarkerCriteria: 若HasBiomarkerCriteria取值为TRUE，则列出对应的生物标志物判定标准（示例：CD22+）。 HasMolecularCriteria: 便捷列项，当HasBiomarkerCriteria或HasGeneticCriteria任一取值为TRUE时，该字段取值为TRUE。 RegimenCode: 关联该适应证的NCCP治疗方案编码（示例：537）。 RegimenName: NCCP治疗方案名称（示例：奥英妥珠单抗单药疗法）。 NCCPRegimenCategories: 该治疗方案关联的NCCP疾病分类（示例：白血病/骨髓移植）。 RegimenURL: 指向NCCP治疗方案文档的访问链接。 Notes: 杂项备注栏，包含来自NCCP治疗方案文档的备注或补充解释。